A Double-Blind, Placebo-Controlled, Randomized Trial of Oral Sodium Clodronate for Metastatic Prostate Cancer (MRC PR05 Trial)

D.P. Dearnaley(Royal Marsden NHS Foundation Trust)
JNCI Journal of the National Cancer Institute
September 2, 2003
Cited by 237


Related Papers